These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4356456)

  • 41. Gilead announces phase I/II data insufficient for marketing clearance of FORVADE topical gel to treat refractory herpes in patients with AIDS.
    AIDS Patient Care STDS; 1997 Aug; 11(4):293. PubMed ID: 11361852
    [No Abstract]   [Full Text] [Related]  

  • 42. Phosphonomethylether compounds as antiviral agents.
    Martin JC; Hitchcock MJ
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):156-8. PubMed ID: 1648822
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of ocular herpes simples infection in rabbits by extracts of Burkitt's lymphoma cell cultures.
    Albert DM; Rabson AS
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):108-11. PubMed ID: 5125503
    [No Abstract]   [Full Text] [Related]  

  • 44. Cidofovir and experimental herpetic stromal disease.
    Kaufman HE; Varnell ED; Thompson HW
    Arch Ophthalmol; 1999 Jul; 117(7):925-8. PubMed ID: 10408458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of metobrine and tebrophene in dermatological practice].
    Samsonov VA; Nikitina MN
    Vestn Dermatol Venerol; 1974 Nov; (11):56-8. PubMed ID: 4446729
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
    J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The efficacy of tai-ding-an on experimental herpetic keratitis in rabbits].
    Chen ZJ; Gao CF; Liu WG; Song JZ
    Yao Xue Xue Bao; 1986 Dec; 21(12):928-30. PubMed ID: 3035866
    [No Abstract]   [Full Text] [Related]  

  • 48. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiviral drugs 1983.
    Douglas RG
    Med Clin North Am; 1983 Sep; 67(5):1163-72. PubMed ID: 6194388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of BW759 (9-[[2-hydroxy-1(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbits.
    Trousdale MD; Nesburn AB; Willey DE; Taaid H
    Curr Eye Res; 1984 Aug; 3(8):1007-15. PubMed ID: 6333319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.
    Hoh HB; Hurley C; Claoue C; Viswalingham M; Easty DL; Goldschmidt P; Collum LM
    Br J Ophthalmol; 1996 Feb; 80(2):140-3. PubMed ID: 8814744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Antimicrob Agents Chemother; 1979 Sep; 16(3):266-70. PubMed ID: 507784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical evaluation of kethoxal against cutaneous herpes simplex.
    Underwood GE; Nichol FR
    Appl Microbiol; 1971 Oct; 22(4):588-92. PubMed ID: 4331769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
    Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.
    De Clercq E; Holý A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):701-6. PubMed ID: 2069375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of topical foscarnet in a new model of herpes simplex skin infection.
    van Genderen J; Wolthuis OL; Ariens AT; Ericson AC; Datema R
    J Antimicrob Chemother; 1987 Oct; 20(4):547-56. PubMed ID: 2960644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
    Toro JR; Sanchez S; Turiansky G; Blauvelt A
    Dermatol Clin; 2003 Apr; 21(2):301-9. PubMed ID: 12757253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
    Machida H; Ikeda T; Ashida N
    Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.